Besremi (ropeginterferon alfa-2b-njft) — Medica
Polycythemia vera
Initial criteria
- Patient is age ≥ 18 years
- Medication is prescribed by or in consultation with an oncologist
Reauthorization criteria
- Patient continues to meet initial criteria
Approval duration
1 year